Royal Bank Of Canada Legend Biotech Corp Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Legend Biotech Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 300 shares of LEGN stock, worth $9,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 799
62.45%
Holding current value
$9,021
Previous $25,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$208 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$202 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$180 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$172 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$113 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.03B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...